N Engl J Med 392(6):612615 Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, Thomas MK, Hartman ML, Haupt A, Milicevic Z, Coskun T (2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Here at Womens Health Network, we believe the most effective approach is one that works with your bodys innate biology
Insulin (10 Qs) Hypoglycemics (10 Qs) Antidiabetics (6 Qs) References American Diabetes Association (2021): 9
Oral semaglutide at doses of 7 and 14 mg/day reduced HbA1c and body weight across the entire spectrum of DM2, as well as other endpoints, such as fasting blood glucose
Tadalafil as needed Tadalafil (generic Cialis) is a PDE5 inhibitor, too, except it has a slower onset and lasts longer in your system